Konstantinidis, I.; Tsokkou, S.; Keramas, A.; Gavriilaki, E.; Delis, G.; Papamitsou, T.
CPX-351 and the Frontier of Nanoparticle-Based Therapeutics in Acute Myeloid Leukemia. Int. J. Mol. Sci. 2025, 26, 11628.
https://doi.org/10.3390/ijms262311628
AMA Style
Konstantinidis I, Tsokkou S, Keramas A, Gavriilaki E, Delis G, Papamitsou T.
CPX-351 and the Frontier of Nanoparticle-Based Therapeutics in Acute Myeloid Leukemia. International Journal of Molecular Sciences. 2025; 26(23):11628.
https://doi.org/10.3390/ijms262311628
Chicago/Turabian Style
Konstantinidis, Ioannis, Sophia Tsokkou, Antonios Keramas, Eleni Gavriilaki, Georgios Delis, and Theodora Papamitsou.
2025. "CPX-351 and the Frontier of Nanoparticle-Based Therapeutics in Acute Myeloid Leukemia" International Journal of Molecular Sciences 26, no. 23: 11628.
https://doi.org/10.3390/ijms262311628
APA Style
Konstantinidis, I., Tsokkou, S., Keramas, A., Gavriilaki, E., Delis, G., & Papamitsou, T.
(2025). CPX-351 and the Frontier of Nanoparticle-Based Therapeutics in Acute Myeloid Leukemia. International Journal of Molecular Sciences, 26(23), 11628.
https://doi.org/10.3390/ijms262311628